Unknown

Dataset Information

0

DNA mismatch repair is not disrupted in stage 0 colorectal cancer resected using endoscopic submucosal dissection.


ABSTRACT: The frequency of deficient mismatch repair (dMMR) or microsatellite instability-high colorectal cancer (CRC) is estimated to be ~15% of all patients with CRC; however, the patients reported are limited to surgical cases, and the frequency of patients exhibiting stage 0 disease is not considered, despite the currently increasing use of endoscopic techniques to cure a number of these patients. In the present study, the DNA MMR status for stage 0 patients with CRC treated using endoscopic submucosal dissection or endoscopic mucosal resection was analyzed via immunohistochemical staining of four types of proteins, namely MutL homolog 1 (MLH1), MutS homolog 2 (MSH2), MSH6 and PMS1 homolog 2 MMR system component, in adenocarcinoma specimens. Notably, none of the endoscopically resected specimens exhibited dMMR among the 41 patients diagnosed with stage 0 CRC. Since tumors harboring dMMR progress more rapidly than tumors with chromosomal instability, the present results highlight the importance of tumor resection during very early phases that exist before the promoter region of MLH1 becomes hypermethylated, resulting in a loss of DNA MMR function.

SUBMITTER: Sugiyama T 

PROVIDER: S-EPMC7399995 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

DNA mismatch repair is not disrupted in stage 0 colorectal cancer resected using endoscopic submucosal dissection.

Sugiyama Tomohiro T   Iwaizumi Moriya M   Kaneko Masanao M   Tani Shinya S   Yamade Mihoko M   Hamaya Yasushi Y   Furuta Takahisa T   Miyajima Hiroaki H   Osawa Satoshi S   Baba Satoshi S   Maekawa Masato M   Sugimoto Ken K  

Oncology letters 20200701 3


The frequency of deficient mismatch repair (dMMR) or microsatellite instability-high colorectal cancer (CRC) is estimated to be ~15% of all patients with CRC; however, the patients reported are limited to surgical cases, and the frequency of patients exhibiting stage 0 disease is not considered, despite the currently increasing use of endoscopic techniques to cure a number of these patients. In the present study, the DNA MMR status for stage 0 patients with CRC treated using endoscopic submucosa  ...[more]

Similar Datasets

| S-EPMC6317950 | biostudies-literature
| S-EPMC3678071 | biostudies-literature
| S-EPMC8759944 | biostudies-literature
| S-EPMC9307737 | biostudies-literature
| S-EPMC8435493 | biostudies-literature
| S-EPMC6064797 | biostudies-literature